0001104659-15-025167.txt : 20150402 0001104659-15-025167.hdr.sgml : 20150402 20150401181308 ACCESSION NUMBER: 0001104659-15-025167 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20141231 FILED AS OF DATE: 20150402 DATE AS OF CHANGE: 20150401 EFFECTIVENESS DATE: 20150402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 15744650 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 12-31-2014 12-31-2014 false Versant Venture Management, LLC
One Sansome Street, Suite 3630 San Francisco CA 94104
13F HOLDINGS REPORT 028-16849 N
Robin L. Praeger Administrative Managing Director, Versant Venture Management (415) 801-8083 /s/ Robin L. Praeger San Francisco CA 03-31-2015 0 5 111097158 false
INFORMATION TABLE 2 a15-8407_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 45630648 814833 SH OTR 0 814833 0 Five Prime Therapeutics, Inc. Common Stock 33830X104 29488104 1092152 SH OTR 0 1092152 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 10307748 1048601 SH OTR 0 1048601 0 Achaogen, Inc. Common Stock 004449104 16719034 1281152 SH OTR 0 1281152 0 Kythera Biopharmaceuticals, Inc. Common Stock 501570105 2440640 70376 SH OTR 0 70376 0